Abstract
The pharmacokinetics of antimigraine drugs zolmitriptan and sumatriptan varied considerably with a fourfold to 10-fold variation in plasma levels. In addition, the pharmacodynamics of triptans as investigated in vitro also varied considerably. In theory, there should probably be a 10-fold variation in doses available, but in clinical practice a fourfold difference in doses will probably cover the needs of most patients.
| Original language | English |
|---|---|
| Journal | Cephalalgia : an international journal of headache |
| Volume | 27 |
| Issue number | 10 |
| Pages (from-to) | 1091-3 |
| Number of pages | 3 |
| ISSN | 0333-1024 |
| DOIs | |
| Publication status | Published - Oct 2007 |
Keywords
- Biological Availability
- Cerebral Arteries
- Dose-Response Relationship, Drug
- Humans
- Migraine Disorders
- Serotonin Receptor Agonists
Fingerprint
Dive into the research topics of 'Pharmacokinetic and pharmacodynamic variability as possible causes for different drug responses in migraine. A comment'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS